Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis

Hideki Garren, William H. Robinson, Eva Krasulová, Eva Havrdová, Congor Nadj, Krzysztof Selmaj, Jacek Losy, Ilinka Nadj, Ernst Wilhelm Radue, Brian A. Kidd, Jill Gianettoni, Karen Tersini, Paul J. Utz, Frank Valone, Lawrence Steinman, Ivan Milanov, Dimitar Georgiev, Penko Shotekov, Paraskeva Stamenova, Slobodan VojinovicPetr Kanovsky, David Dolezil, Edvard Ehler, Otakar Keller, Pavel Stourac, Juha Pekka Erälinna, Keijo Koivisto, Jussi Valpas, Yuriy Golovchenko, Larysa Sokolova, Anatoliy Grinchuk, Sergiy Moskovko, Hubert Kwiecinski, Andrzej Wajgt, Andrzej Tutaj, Ryszard Podemski, Sanda Nica, Rodica Balasa, Mihaela Adriana Simu, Igor Stolyarov, Miroslav Odinak, Alexander Skoromets, Eugeny Gusev, Igor Zavalishin, Anna N. Belova, Leonid Zaslavskiy, Peter Turcani, Lubica Prochazkova, Juraj Vyletelka, Egon Kurca, Jarmila Szilasiova, Christopher Hawkes, Basil Sharrack, Lloyd Kasper

Research output: Contribution to journalArticlepeer-review

164 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science